ADVANCED ENDOMETRIAL CANCER
Clinical trials for ADVANCED ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for ADVANCED ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced endometrial cancer: immune drug combo under study
Disease control Recruiting nowThis study tests a drug called envafolimab, given alone or with lenvatinib, in people with advanced endometrial cancer that has not responded to standard chemotherapy. The goal is to see if the treatment shrinks tumors. About 108 participants will take part. This is an early-phas…
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: 3D Medicines (Sichuan) Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 14:57 UTC
-
New IgE antibody trial targets Hard-to-Treat ovarian and breast cancers
Disease control Recruiting nowThis early-phase trial tests an experimental drug called MOv18 IgE in people with advanced ovarian, endometrial, or triple-negative breast cancers that have high levels of a protein called folate receptor alpha. The study has two parts: first, finding a safe dose, and then checki…
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE1 • Sponsor: Epsilogen Ltd • Aim: Disease control
Last updated May 15, 2026 11:53 UTC